Stockscreener 앱 받기
30.19
1.21%
0.34
Newamsterdam Pharma Company Nv 주식(NAMS)의 최신 뉴스
NewAmsterdam Pharma (NAMS) outlines 2026 AGM votes, ESPP and share issuance powers - Stock Titan
(NAMS) Volatility Zones as Tactical Triggers - Stock Traders Daily
Five new hires at NewAmsterdam get stock awards covering 65,800 shares - Stock Titan
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Pictet Asset Management Holding SA Lowers Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Jennison Associates LLC Trims Stock Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
What sustainable investing NewAmsterdam (NAMSW)? (+5.61%) 2026-04-29Community Watchlist - Newser
143,549 Shares in NewAmsterdam Pharma Company N.V. $NAMS Bought by Moody Aldrich Partners LLC - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 8%What's Next? - MarketBeat
NAMSW Price History for Newamsterdam Pharma Company N.V. WT Stock - Barchart.com
Understanding Momentum Shifts in (NAMSW) - Stock Traders Daily
NewAmsterdam Pharma Company N.V. Files 8-K with SEC: Company Information, NASDAQ Listing, and Key Filing Details - Minichart
NewAmsterdam Pharma Announces Chief Accounting Officer Transition Agreement - TipRanks
NewAmsterdam Pharma (NAMS) details CAO exit, bonus and equity terms - Stock Titan
NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares) reports wider-than-expected Q4 2025 losses, stock dips 1.25% as revenue halves year-over-year.Most Discussed Stocks - Xã Thanh Hà
NewAmsterdam Pharma Co. NV Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares) posts wider than expected Q4 2025 loss, shares rise 4.46 percent on upbeat investor sentiment.Social Momentum Signals - Cổng thông tin điện tử tỉnh Tây Ninh
NAMSW (NewAmsterdam) does not disclose core quarterly earnings metrics as investors await further operational guidance details.Growth Pick - Cổng thông tin điện tử tỉnh Tây Ninh
Price-Driven Insight from (NAMS) for Rule-Based Strategy - Stock Traders Daily
What is limiting NewAmsterdam (NAMS) stock performance (Breakout Watch) 2026-04-20Community Risk Signals - Xã Thanh Hà
NewAmsterdam Pharma (NAMS) AGM June 2, 2026: ESPP, auditors, director votes - Stock Titan
Avoiding Lag: Real-Time Signals in (NAMSW) Movement - Stock Traders Daily
NewAmsterdam Pharma: Cholesterol-Lowering Player Is A Risk-On Buy Today (NASDAQ:NAMS) - Seeking Alpha
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Resistance Check: What are the risks of holding NewAmsterdam Pharma Company NV Equity WarrantQuarterly Trade Review & Real-Time Buy Zone Alerts - baoquankhu1.vn
NewAmsterdam Pharma Company (NAMS): Huge upside potential grabs attention of billionaire Stan Druckenmiller - MSN
Pullback Watch: What are the risks of holding NewAmsterdam Pharma Company NV Equity Warrant2026 Fed Impact & Weekly Return Optimization Plans - baoquankhu1.vn
(NAMS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Published on: 2026-04-11 17:21:30 - baoquankhu1.vn
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference - Sahm
A Look At NewAmsterdam Pharma (NAMS) Valuation As Hedge Funds Focus On Obicetrapib’s Phase 3 LDL C Results - Yahoo Finance
NewAmsterdam Pharma Company (NAMS): Huge Upside Potential Grabs Attention of Billionaire Stan Druckenmiller - Insider Monkey
Gains Report: Will NewAmsterdam Pharma Company NV Equity Warrant benefit from AI trendsEntry Point & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Does NewAmsterdam Pharma (NAMS) CETP Optimism Point To A Durable Edge In Cardiovascular Treatment? - Sahm
Short Squeeze: Will NewAmsterdam Pharma Company NV stock recover after earnings2026 Retail Activity & Weekly High Return Forecasts - baoquankhu1.vn
Billionaire Stan Druckenmiller’s 5 Small and Mid-Cap Stock Picks with Huge Upside Potential - Insider Monkey
Is NewAmsterdam (NAMSW) Stock Attractive Now | Price at $23.71, Up 12.53%Expert Momentum Signals - Xã Châu Thành
Aberdeen Group plc Has $25.59 Million Stock Holdings in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Is NewAmsterdam (NAMS) Stock a Good Buy in 2026 | Price at $33.00, Up 0.03%Social Buy Zones - Xã Vĩnh Công
Discipline and Rules-Based Execution in NAMSW Response - Stock Traders Daily
Will NewAmsterdam Pharma Company NV benefit from seasonality2026 Key Highlights & Trade Opportunity Analysis - baoquankhu1.vn
NAMS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NAMS Stock Analysis: NewAmsterdam Pharma 0.55 pct daily gain 32.99 price outlook - UBND thành phố Hải Phòng
Two new hires get 15,000 stock options and 3,200 RSUs at NewAmsterdam - Stock Titan
Here’s Why NewAmsterdam Pharma Company N.V. (NAMS) Surged 23% in Q4 - Insider Monkey
NAMSW SEC FilingsNewAmsterdam Pha 10-K, 10-Q, 8-K Forms - Stock Titan
Pullback Watch: Is NewAmsterdam Pharma Company NV Equity Warrant stock trending bullish2026 Buyback Activity & Daily Technical Forecast Reports - baoquankhu1.vn
(NAMS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Revenue Check: Does NewAmsterdam Pharma Company NV have declining or rising EPSWeekly Gains Summary & Safe Entry Trade Reports - baoquankhu1.vn
0.78%
3.01%
자본화:
|
볼륨(24시간):